IBA Reports Full Year 2023 Results

GROUP REVENUES UP 18.7% WITH OTHER ACCELERATORS UP 51.1%

REBIT POSITIVE FOR FY23 WITH OTHER ACCELERATORS REBIT ALMOST QUADRUPLING

MEDIUM TERM GUIDANCE REITERATED

Louvain-la-Neuve, Belgium, 21 March 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the 2023 financial year.

(EUR 000)	FY 2023	FY 2022	Variance	Variance %
Total Net Sales	428 717	361 270	67 447	18.7%
Proton Therapy	229 065	218 761	10 304	4.7%
Other Accelerators	133 742	88 538	45 204	51.1%
Dosimetry	65 910	53 971	11 939	22.1%
REBITDA	19 308	21 571	-2 263	-10.5%
% of Sales	4.5%	6.0%
REBIT	6 417	11 050	-4 633	-41.9%
% of Sales	1.5%	3.1%
Profit Before Tax	-315	-430	115	-26.7%
% of Sales	-0.1%	-0.1%
NET RESULT	-9 110	6 057	-15 167	-250.4%
% of Sales	-2.1%	1.7%

Olivier Legrain, Chief Executive Officer of IBA, commented: “A strong second half performance has ensured we have delivered positive REBIT at the full year, with Group revenues in line with expectations.”